JPY 2325.0
(-0.73%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 70.7 Billion JPY | 1.95% |
2022 | 69.35 Billion JPY | 0.24% |
2021 | 69.18 Billion JPY | 5.34% |
2020 | 65.67 Billion JPY | 27.59% |
2019 | 51.47 Billion JPY | 0.77% |
2018 | 51.08 Billion JPY | 1.38% |
2017 | 50.39 Billion JPY | -0.91% |
2016 | 50.85 Billion JPY | -7.73% |
2015 | 55.11 Billion JPY | 63.54% |
2014 | 33.69 Billion JPY | -17.32% |
2013 | 40.75 Billion JPY | -1.4% |
2012 | 41.33 Billion JPY | -7.54% |
2011 | 44.7 Billion JPY | -1.43% |
2010 | 45.35 Billion JPY | 5.54% |
2009 | 42.97 Billion JPY | 41.38% |
2008 | 30.39 Billion JPY | 10.69% |
2007 | 27.46 Billion JPY | -5.05% |
2006 | 28.92 Billion JPY | 6.39% |
2005 | 27.18 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 69.93 Billion JPY | -1.08% |
2023 Q4 | 70.7 Billion JPY | -4.88% |
2023 Q3 | 74.33 Billion JPY | 2.96% |
2023 Q2 | 72.19 Billion JPY | 0.64% |
2023 FY | 70.7 Billion JPY | 1.95% |
2023 Q1 | 71.74 Billion JPY | 3.44% |
2022 Q3 | 71.08 Billion JPY | -2.06% |
2022 FY | 69.35 Billion JPY | 0.24% |
2022 Q4 | 69.35 Billion JPY | -2.44% |
2022 Q1 | 71.94 Billion JPY | 3.99% |
2022 Q2 | 72.58 Billion JPY | 0.89% |
2021 Q4 | 69.18 Billion JPY | -1.84% |
2021 Q1 | 68.19 Billion JPY | 3.83% |
2021 FY | 69.18 Billion JPY | 5.34% |
2021 Q3 | 70.48 Billion JPY | 4.8% |
2021 Q2 | 67.25 Billion JPY | -1.38% |
2020 Q2 | 52.81 Billion JPY | -1.55% |
2020 Q3 | 65.51 Billion JPY | 24.03% |
2020 Q4 | 65.67 Billion JPY | 0.25% |
2020 FY | 65.67 Billion JPY | 27.59% |
2020 Q1 | 53.64 Billion JPY | 4.22% |
2019 FY | 51.47 Billion JPY | 0.77% |
2019 Q4 | 51.47 Billion JPY | -4.44% |
2019 Q3 | 53.87 Billion JPY | 2.9% |
2019 Q2 | 52.35 Billion JPY | -1.47% |
2019 Q1 | 53.13 Billion JPY | 4.0% |
2018 Q2 | 49.03 Billion JPY | 0.6% |
2018 FY | 51.08 Billion JPY | 1.38% |
2018 Q1 | 48.74 Billion JPY | -3.26% |
2018 Q3 | 53.12 Billion JPY | 8.34% |
2018 Q4 | 51.08 Billion JPY | -3.85% |
2017 Q3 | 50.85 Billion JPY | -3.38% |
2017 Q1 | 51.15 Billion JPY | 0.6% |
2017 FY | 50.39 Billion JPY | -0.91% |
2017 Q4 | 50.39 Billion JPY | -0.92% |
2017 Q2 | 52.63 Billion JPY | 2.89% |
2016 FY | 50.85 Billion JPY | -7.73% |
2016 Q2 | 52 Billion JPY | -3.7% |
2016 Q1 | 54 Billion JPY | -2.01% |
2016 Q3 | 54.07 Billion JPY | 3.99% |
2016 Q4 | 50.85 Billion JPY | -5.96% |
2015 Q1 | 29.98 Billion JPY | -11.01% |
2015 FY | 55.11 Billion JPY | 63.54% |
2015 Q4 | 55.11 Billion JPY | -0.96% |
2015 Q3 | 55.64 Billion JPY | 5.82% |
2015 Q2 | 52.58 Billion JPY | 75.35% |
2014 Q4 | 33.69 Billion JPY | -0.47% |
2014 Q2 | 36.26 Billion JPY | -1.04% |
2014 Q3 | 33.85 Billion JPY | -6.64% |
2014 FY | 33.69 Billion JPY | -17.32% |
2014 Q1 | 36.64 Billion JPY | -10.09% |
2013 FY | 40.75 Billion JPY | -1.4% |
2013 Q1 | 38.2 Billion JPY | -7.58% |
2013 Q2 | 39.61 Billion JPY | 3.7% |
2013 Q3 | 43.37 Billion JPY | 9.48% |
2013 Q4 | 40.75 Billion JPY | -6.02% |
2012 Q1 | 44.9 Billion JPY | 0.45% |
2012 FY | 41.33 Billion JPY | -7.54% |
2012 Q4 | 41.33 Billion JPY | -5.04% |
2012 Q3 | 43.53 Billion JPY | 0.19% |
2012 Q2 | 43.45 Billion JPY | -3.25% |
2011 Q1 | 46.13 Billion JPY | 1.72% |
2011 Q2 | 45.6 Billion JPY | -1.15% |
2011 Q4 | 44.7 Billion JPY | -4.84% |
2011 FY | 44.7 Billion JPY | -1.43% |
2011 Q3 | 46.98 Billion JPY | 3.02% |
2010 Q3 | 46.78 Billion JPY | 2.79% |
2010 FY | 45.35 Billion JPY | 5.54% |
2010 Q2 | 45.52 Billion JPY | 12.45% |
2010 Q1 | 40.48 Billion JPY | -5.8% |
2010 Q4 | 45.35 Billion JPY | -3.06% |
2009 Q3 | 43.47 Billion JPY | -0.06% |
2009 Q4 | 42.97 Billion JPY | -1.14% |
2009 Q2 | 43.49 Billion JPY | 0.0% |
2009 FY | 42.97 Billion JPY | 41.38% |
2008 Q3 | 31.63 Billion JPY | 0.0% |
2008 Q4 | 30.39 Billion JPY | -3.92% |
2008 FY | 30.39 Billion JPY | 10.69% |
2007 FY | 27.46 Billion JPY | -5.05% |
2006 FY | 28.92 Billion JPY | 6.39% |
2005 FY | 27.18 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -182.955% |
Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.098% |
Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 90.59% |
Shionogi & Co., Ltd. | 164.35 Billion JPY | 56.98% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -1982.628% |
Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -64.936% |
Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -153.731% |
Eisai Co., Ltd. | 494.82 Billion JPY | 85.711% |
Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -1302.873% |
Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | -14.606% |
Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -129.323% |
Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -77.677% |
Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -127.464% |
Tsumura & Co. | 132.88 Billion JPY | 46.793% |
Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -77.69% |
Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -431.735% |
Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 74.267% |
Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -60.118% |
KYORIN Holdings, Inc. | 46.89 Billion JPY | -50.779% |
Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -909.636% |
Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -177.939% |
SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -768.382% |
MedRx Co., Ltd | 129 Million JPY | -54709.922% |
Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -2060.551% |
Solasia Pharma K.K. | 673 Million JPY | -10405.914% |
Modalis Therapeutics Corporation | 645.5 Million JPY | -10853.442% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -125.311% |
Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 56.886% |
Cyfuse Biomedical K.K. | 1.01 Billion JPY | -6891.2% |
Toho Holdings Co., Ltd. | 523.98 Billion JPY | 86.506% |
Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -916.993% |